Terms: = Prostate cancer AND TG, Thyroglobulin AND Diagnosis
16 results:
1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
[TBL] [Abstract] [Full Text] [Related]
2. Head-to-Head Comparison of
Pitalua-Cortes Q; García-Perez FO; Vargas-Ahumada J; Gonzalez-Rueda S; Gomez-Argumosa E; Ignacio-Alvarez E; Soldevilla-Gallardo I; Torres-Agredo L
Front Endocrinol (Lausanne); 2021; 12():794759. PubMed ID: 35002972
[TBL] [Abstract] [Full Text] [Related]
3. Based on biomedical index data: Risk prediction model for prostate cancer.
Guo H; Jia X; Liu H
Medicine (Baltimore); 2021 Apr; 100(17):e25602. PubMed ID: 33907111
[TBL] [Abstract] [Full Text] [Related]
4. Oncocytic poorly differentiated (insular) thyroid carcinoma mimicking metastatic adenocarcinoma. A case report and review of the literature.
Laforga JB; Cortés VA
Diagn Cytopathol; 2019 Jun; 47(6):584-588. PubMed ID: 30637975
[TBL] [Abstract] [Full Text] [Related]
5. Multiplex measurement of twelve tumor markers using a GMR multi-biomarker immunoassay biosensor.
Gao Y; Huo W; Zhang L; Lian J; Tao W; Song C; Tang J; Shi S; Gao Y
Biosens Bioelectron; 2019 Jan; 123():204-210. PubMed ID: 30174274
[TBL] [Abstract] [Full Text] [Related]
6. Association of endothelin-1 gene single-nucleotide polymorphisms and haplotypes with risk of hormone refractory prostate cancer.
Xu D; Wang X; Lou Y
Pharmazie; 2017 Feb; 72(2):103-106. PubMed ID: 29441862
[TBL] [Abstract] [Full Text] [Related]
7. The Comparison and Estimation of the Prognostic Value of Lipid Profiles in Patients With prostate cancer Depends on cancer Stage Advancement.
Wolny-Rokicka EI; Tukiendorf A; Wydmański J; Zembroń-Łacny A
Am J Mens Health; 2017 Nov; 11(6):1745-1751. PubMed ID: 28726527
[TBL] [Abstract] [Full Text] [Related]
8. A systematic analysis of commonly used antibodies in cancer diagnostics.
Gremel G; Bergman J; Djureinovic D; Edqvist PH; Maindad V; Bharambe BM; Khan WA; Navani S; Elebro J; Jirström K; Hellberg D; Uhlén M; Micke P; Pontén F
Histopathology; 2014 Jan; 64(2):293-305. PubMed ID: 24330150
[TBL] [Abstract] [Full Text] [Related]
9. Association of six susceptibility Loci with prostate cancer in northern chinese men.
Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z
Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444
[TBL] [Abstract] [Full Text] [Related]
10. Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects.
Wang L; Kaku H; Huang P; Xu K; Yang K; Zhang J; Li M; Xie L; Wang X; Sakai A; Watanabe M; Nasu Y; Shimizu K; Kumon H; Na Y
Acta Med Okayama; 2011 Oct; 65(5):315-23. PubMed ID: 22037268
[TBL] [Abstract] [Full Text] [Related]
11. The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years.
Hayashi N; Matsushima M; Yamamoto T; Sasaki H; Takahashi H; Egawa S
BJU Int; 2012 Feb; 109(4):515-9. PubMed ID: 21812901
[TBL] [Abstract] [Full Text] [Related]
12. No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
Jaboin JJ; Hwang M; Perez CA; Cooper C; Chen H; Ye C; Cai Q; Wills ML; Lu B
Urol Oncol; 2011; 29(3):319-23. PubMed ID: 19523862
[TBL] [Abstract] [Full Text] [Related]
13. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract] [Full Text] [Related]
14. [Immunohistochemical diagnosis in cancer metastasis of unknown primary tumor].
Kaufmann O; Fietze E; Dietel M
Pathologe; 2002 May; 23(3):183-97. PubMed ID: 12089786
[TBL] [Abstract] [Full Text] [Related]
15. Experiences of the Janus Serum Bank in Norway.
Jellum E; Andersen A; Lund-Larsen P; Theodorsen L; Orjasaeter H
Environ Health Perspect; 1995 Apr; 103 Suppl 3(Suppl 3):85-8. PubMed ID: 7635118
[TBL] [Abstract] [Full Text] [Related]
16. [An immunohistological study of metastatic adenocarcinoma of the lymph node: is it useful in diagnosing a primary tumor?].
Hamaya K; Doi K; Yoshizawa S; Motoi M
Gan No Rinsho; 1988 Nov; 34(14):1956-60. PubMed ID: 2462648
[TBL] [Abstract] [Full Text] [Related]
